These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 11757174

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice.
    Ji B, Perani EG, Petinon C, Grosset JH.
    Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):556-61. PubMed ID: 1338596
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V, Saha B, Hajra SK, Biswas SK, Saha K.
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [Abstract] [Full Text] [Related]

  • 4. Search for newer antileprosy drugs.
    Dhople AM.
    Indian J Lepr; 2000 Sep; 72(1):5-20. PubMed ID: 10935183
    [Abstract] [Full Text] [Related]

  • 5. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I, Cartel JL, Grosset JH.
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy.
    Joseph P, Ponnaiya J, Das M, Chaitanya VS, Arumugam S, Ebenezer M.
    Indian J Lepr; 2016 Jun; 88(3):147-58. PubMed ID: 30207440
    [Abstract] [Full Text] [Related]

  • 7. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
    Pai VV, Bulchand HO, Revankar CR, Ganapati R.
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
    [No Abstract] [Full Text] [Related]

  • 8. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
    Matsuoka M, Kashiwabara Y, Namisato M.
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
    [Abstract] [Full Text] [Related]

  • 9. Assessment of viability by normal mouse foot-pad and bacillary ATP bioluminescence assay in multibacillary cases treated with an MDT regimen using conventional as well as newer drugs like minocycline and ofloxacin.
    Gupta UD, Katoch K, Singh HB, Natrajan M, Sharma VD, Katoch VM.
    Indian J Lepr; 2000 Dec; 72(4):437-42. PubMed ID: 11212477
    [Abstract] [Full Text] [Related]

  • 10. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
    Ganapati R, Revankar CR, Pai VV, Kingsley S.
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
    [No Abstract] [Full Text] [Related]

  • 11. Bactericidal activities of HMR 3647, moxifloxacin, and rifapentine against Mycobacterium leprae in mice.
    Consigny S, Bentoucha A, Bonnafous P, Grosset J, Ji B.
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2919-21. PubMed ID: 10991891
    [Abstract] [Full Text] [Related]

  • 12. In vivo susceptibility of Mycobacterium leprae to ofloxacin either singly or in combination with rifampicin and rifabutin. Anti-leprosy activity of ofloxacin and ansamycins in mice.
    Dhople AM, Ibanez MA.
    Arzneimittelforschung; 1994 Apr; 44(4):563-5. PubMed ID: 8011013
    [Abstract] [Full Text] [Related]

  • 13. Multi-drug therapy of leprosy.
    Ramu G.
    Indian J Lepr; 1985 Apr; 57(3):465-82. PubMed ID: 2420903
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Drug resistance of Mycobacterium leprae].
    Pattyn SR.
    Acta Leprol; 1986 Apr; 4(3):279-87. PubMed ID: 3551466
    [No Abstract] [Full Text] [Related]

  • 16. Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy.
    Lenz SM, Collins JH, Ray NA, Hagge DA, Lahiri R, Adams LB.
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008583. PubMed ID: 32936818
    [Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo interactions of drugs used in multidrug therapy in leprosy.
    Dhople AM, Lamoureux LC, Gardner GD.
    Indian J Lepr; 1991 Sep; 63(2):166-79. PubMed ID: 1664440
    [Abstract] [Full Text] [Related]

  • 18. [New WHO recommendations for the treatment of leprosy].
    Acta Leprol; 1997 Sep; 10(4):189. PubMed ID: 9527754
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.